Cargando…

Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

SIMPLE SUMMARY: In locally advanced or metastatic non-small cell lung cancer (NSCLC), immunotherapy has become a standard as it can improve overall survival and progression-free survival. However, a durable clinical benefit (DCB) is only achieved in 20–50% of patients. Early identification of patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tankyevych, Olena, Trousset, Flora, Latappy, Claire, Berraho, Moran, Dutilh, Julien, Tasu, Jean Pierre, Lamour, Corinne, Cheze Le Rest, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739232/ https://www.ncbi.nlm.nih.gov/pubmed/36497415 http://dx.doi.org/10.3390/cancers14235931

Ejemplares similares

Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer
por: Sepehri, Shima, et al.
Publicado: (2021)

Accurate Tumor Delineation vs. Rough Volume of Interest Analysis for (18)F-FDG PET/CT Radiomics-Based Prognostic Modeling inNon-Small Cell Lung Cancer
por: Sepehri, Shima, et al.
Publicado: (2021)

Transcriptomics in cancer revealed by Positron Emission Tomography radiomics
por: Tixier, Florent, et al.
Publicado: (2020)

Radiogenomics in Colorectal Cancer
por: Badic, Bogdan, et al.
Publicado: (2021)

Correlation of Intra-Tumor (18)F-FDG Uptake Heterogeneity Indices with Perfusion CT Derived Parameters in Colorectal Cancer
por: Tixier, Florent, et al.
Publicado: (2014)

Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy
por: McGale, Jeremy, et al.
Publicado: (2023)

[(18)F]FDG PET Immunotherapy Radiomics Signature (iRADIOMICS) Predicts Response of Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
por: Valentinuzzi, Damijan, et al.
Publicado: (2020)

Role of radiomics in predicting immunotherapy response
por: Kothari, Gargi
Publicado: (2022)

Revisiting the identification of tumor sub-volumes predictive of residual uptake after (chemo)radiotherapy: influence of segmentation methods on (18)F-FDG PET/CT images
por: Hatt, Mathieu, et al.
Publicado: (2019)

Use of baseline 18F-FDG PET scan to identify initial sub-volumes with local failure after concomitant radio-chemotherapy in head and neck cancer
por: Legot, Floriane, et al.
Publicado: (2018)

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Cousin, François, et al.
Publicado: (2023)

Radiomic biomarkers of tumor immune biology and immunotherapy response
por: Wang, Jarey H., et al.
Publicado: (2021)

Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy
por: Dercle, Laurent, et al.
Publicado: (2022)

Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics
por: Barabino, Emanuele, et al.
Publicado: (2022)

Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC
por: Bouhamama, Amine, et al.
Publicado: (2023)

A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023)

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
por: Trebeschi, S, et al.
Publicado: (2019)

Compact FTICR Mass Spectrometry for Real Time Monitoring of Volatile Organic Compounds
por: Lemaire, Joël, et al.
Publicado: (2018)

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
por: Singh, Apurva, et al.
Publicado: (2022)

Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023)

Éditorial
por: Tasu, J.-P.
Publicado: (2020)

Use of Radiomics to Predict Response to Immunotherapy of Malignant Tumors of the Digestive System
por: Ji, Zhi, et al.
Publicado: (2020)

Delta-radiomics in cancer immunotherapy response prediction: A systematic review
por: Abbas, Engy, et al.
Publicado: (2023)

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
por: Polverari, Giulia, et al.
Publicado: (2020)

Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer
por: Tunali, Ilke, et al.
Publicado: (2021)

Evaluation of Multidimensional Functional Impairment in Adult Sexual Assault Survivors, with a Focus on Its Psychological, Physical, and Social Dimensions, Based on Validated Measurements: A PRISMA Systematic Review
por: Schalk, Thibault, et al.
Publicado: (2023)

La nueva guerra del opio
por: Lamour, Catherine
Publicado: (1973)

Las grandes manceuvres de l'opium
por: Lamour, Catherine
Publicado: (1972)

Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics
por: Devkota, Laxman, et al.
Publicado: (2020)

PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature
por: Evangelista, Laura, et al.
Publicado: (2023)

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
por: Sun, Roger, et al.
Publicado: (2020)

Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
por: He, Bingxi, et al.
Publicado: (2020)

CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy
por: Lin, Qian, et al.
Publicado: (2022)

Radiomic biomarkers from chest computed tomography are assistive in immunotherapy response prediction for non-small cell lung cancer
por: Schroeder, Kimberly E., et al.
Publicado: (2023)

Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study
por: Rossi, Ernesto, et al.
Publicado: (2023)

Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians
por: Zhou, Huijie, et al.
Publicado: (2023)

Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab
por: Ammari, Samy, et al.
Publicado: (2021)

A computational account of why more valuable goals seem to require more effortful actions
por: Bioud, Emmanuelle, et al.
Publicado: (2022)

Identification of Psycho-Socio-Judicial Trajectories and Factors Associated With Posttraumatic Stress Disorder in People Over 15 Years of Age Who Recently Reported Sexual Assault to a Forensic Medical Center: Protocol for a Multicentric Prospective Study Using Mixed Methods and Artificial Intelligence
por: Fedele, Emma, et al.
Publicado: (2023)

Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy
por: Davey, Angela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vthotd31p74n6d5es3godf2q6p